We are live on
!
Find out more
MDSL
M.D. Sass LLC Portfolio holdings
AUM
$1.32B
1-Year Est. Return
16.01%
This Fund
S&P 500
This Quarter
Est. Return
-3.18%
1 Year Est. Return
+16.01%
3 Year Est. Return
+54.62%
5 Year Est. Return
+70.79%
10 Year Est. Return
+248.43%
AUM
$1.39B
AUM Growth
+$505M
(+57%)
Cap. Flow
+$532M
Cap. Flow
% of AUM
38.22%
Top 10 Holdings %
Top 10 Hldgs %
59.69%
Holding
38
New
4
Increased
25
Reduced
3
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marvell Technology
MRVL
|
+$70.6M |
| 2 |
Ametek
AME
|
+$49.1M |
| 3 |
Jabil
JBL
|
+$37.3M |
| 4 |
Charles River Laboratories
CRL
|
+$36.1M |
| 5 |
Liberty Media Series C
FWONK
|
+$33.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chemed
CHE
|
+$32.8M |
| 2 |
Warner Music
WMG
|
+$23.6M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$19.6M |
| 4 |
Blue Owl Capital
OWL
|
+$17.1M |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$10.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.35% |
| 2 | Industrials | 18.43% |
| 3 | Healthcare | 10.54% |
| 4 | Consumer Staples | 9.59% |
| 5 | Real Estate | 8.01% |
Similar funds
LCS
CC
CP
IEFM
GSEP
TIM
MCM
HCM
M.D. Sass LLC's Q2 2024 Portfolio in Review
As of Q2 2024, M.D. Sass LLC held 38 positions worth $1.39B, up 57% from $887M the previous quarter. Its ten largest holdings account for 60% of the portfolio.
M.D. Sass LLC deployed $532M of net new capital in Q2 2024, opening 4 new positions and adding to 25 existing holdings. Its largest new stake was Marvell Technology: 1,007,381 shares worth $70.4M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 14% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $19.6M trimmed.
- M.D. Sass LLC's largest Q2 2024 buy was Marvell Technology: 1,007,381 shares worth $70.4M.
- M.D. Sass LLC added most to Jabil in Q2 2024, an estimated $37.3M increase.
- M.D. Sass LLC's biggest Q2 2024 reduction was Vanguard S&P 500 ETF, cutting an estimated $19.6M.
- M.D. Sass LLC fully exited Chemed in Q2 2024, selling an estimated $32.8M.
- M.D. Sass LLC's ten largest holdings make up 60% of its $1.39B portfolio in Q2 2024.
- M.D. Sass LLC opened 4 new positions and closed 5 in Q2 2024.
- M.D. Sass LLC's portfolio value rose 57% quarter-over-quarter to $1.39B.
Based on M.D. Sass LLC's 13F filing for Q2 2024, filed 13 Aug 2024.